• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Recombinant human DNase in conditions other than cystic fibrosis].

作者信息

Kristensen Kim

机构信息

Paediatrisk Klinik 2, 4072, Rigshospitalet, DK-2100 København Ø, Denmark.

出版信息

Ugeskr Laeger. 2010 Feb 22;172(8):616-9.

PMID:20184817
Abstract

Recombinant human DNase (rhDNase) reduces viscosity of sputum. Effect has been documented in cystic fibrosis and postoperatively in paediatric heart disease. Single dose treatment with rhDNase in paediatric asthma has no effect. In respiratory syncytial virus infection, treatment with rhDNase may be associated with increased need for supplemental oxygen. In adults with idiopathic bronchiectasis, treatment with rhDNase leads to more pulmonary exacerbations and a greater decline in pulmonary function tests. There are no controlled studies on rhDNase in primary ciliary dyskinesia or atelectasis.

摘要

相似文献

1
[Recombinant human DNase in conditions other than cystic fibrosis].
Ugeskr Laeger. 2010 Feb 22;172(8):616-9.
2
DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.脱氧核糖核酸酶治疗重症呼吸道合胞病毒细支气管炎患儿肺不张
Eur Respir J. 2001 Oct;18(4):734-7.
3
Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?在囊性纤维化中，用支气管镜给予重组人脱氧核糖核酸酶治疗肺叶肺不张？
Clin Respir J. 2008 Apr;2(2):123-6. doi: 10.1111/j.1752-699X.2007.00024.x.
4
Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.
Chest. 1998 May;113(5):1329-34. doi: 10.1378/chest.113.5.1329.
5
Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns.
Pediatr Int. 2011 Jun;53(3):328-31. doi: 10.1111/j.1442-200X.2010.03245.x.
6
Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
J Aerosol Med. 2003 Summer;16(2):175-82. doi: 10.1089/089426803321919933.
7
Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome.雾化吸入人重组脱氧核糖核酸酶对卡塔格内综合征的临床疗效。
Pediatr Pulmonol. 1995 Nov;20(5):307-8. doi: 10.1002/ppul.1950200509.
8
Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):413-7. doi: 10.1164/ajrccm.154.2.8756815.
9
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.雾化重组人脱氧核糖核酸酶对囊性纤维化患者呼吸道症状加重及肺功能的影响。Pulmozyme研究组。
N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003.
10
Endotracheal DNase for atelectasis in ventilated neonates.气管内 DNA 酶治疗机械通气新生儿肺不张。
J Perinatol. 2011 Dec;31(12):799-801. doi: 10.1038/jp.2011.38.

引用本文的文献

1
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张症患者的气道炎症标志物。
J Inflamm Res. 2013;6:1-11. doi: 10.2147/JIR.S40081. Epub 2013 Jan 23.